Absci (ABSI) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


ABSI Absci Corp ABSI
47 GF Score
Price $10.08
GF Value $0.94
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Absci Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Absci's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ABSI vs CRVS, JBIO, SVRA: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Absci's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Absci Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Absci's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Absci's Margin of Safety % (DCF Earnings Based) falls into.


ABSI
47GF Score
Absci Corp ABSI
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Absci (ABSI) Overvalued in 2026?

Based on GuruFocus' analysis, Absci stock appears to be overvalued. The current stock price of $10.08 is trading 971.8% above its estimated GF Value™ of $0.94. GuruFocus considers Absci to be Significantly Overvalued.

Key valuation signals for ABSI:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $0.94 vs. price of $10.08 (971.8% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the ABSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Absci Business Description

Address 18105 SE Mill Plain Boulevard, Vancouver, WA, USA, 98683
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
47GF Score

Get the complete analysis for ABSI

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.08
Price
$0.94
GF Value